Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Cough assessment is central to the clinical management of respiratory diseases, including
tuberculosis (TB), but strategies to objectively and unobtrusively measure cough are lacking …

Background Directly observed treatment (DOT) has been the standard of care for
tuberculosis since the early 1990s, but it is inconvenient for patients and service providers …

Poor medication adherence may increase rates of loss to follow-up, disease relapse and
drug resistance for individuals with active tuberculosis (TB). While TB programmes have …

Background Non-adherence to tuberculosis (TB) treatment is the most important cause of
poor TB outcomes, and improving support for TB patients is a primary priority for …

Background Mobile health (mHealth) interventions have the potential to improve health
through patient education and provider engagement while increasing efficiency and …

Background Tuberculosis (TB) is the leading cause of death from a single infectious agent,
with around 1.5 million deaths reported in 2018, and is a major contributor to suffering …

Directly observed therapy (DOT) for monitoring tuberculosis (TB) treatment is intended to
reduce disease transmission, mortality and acquired drug resistance by facilitating treatment …

Facility-based directly observed therapy (DOT) has been the standard for treating people
with TB since the early 1990s. As the commitment to promote a people-centred model of …

Ensuring adherence and support during treatment of tuberculosis (TB) is a major public
health challenge. Digital health technologies could help improve treatment outcomes. We …